Word

C THE S!GNS

Status

Pending

Status Code

730

Status Date

Tuesday, February 27, 2024

Serial Number

97235079

Mark Type

3000

Filing Date

Monday, January 24, 2022

Published for Opposition

Tuesday, July 18, 2023

Trademark Owner History

C the Signs Limited - Owner At Publication

Classifications

41 (Based on 44(e)) Educational and training services relating to healthcare, namely, conducting training, workshops, classes in the field of healthcare; (Based on Intent To Use) education services, namely, conducting training, workshops, classes in the field of healthcare; providing of training in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients, rendered through correspondence courses; teaching in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; arranging and conducting of conferences, seminars and training workshops in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; providing education in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients rendered through correspondence courses; educational services, namely, conducting classes, workshops, seminars in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; vocational guidance; organisation of exhibitions for educational purposes; providing on-line electronic publications in the nature of books, magazines, brochures, leaflets in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

9 (Based on 44(e)) Downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; (Based on Intent To Use) downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; computer software platforms, recorded or downloadable for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; digital media, namely, downloadable audio and audiovisual recordings featuring information and advice relating to cancer risk, cancer diagnosis, cancer treatment and the clinical needs of patients; multi-platform digital tools, namely, downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; all of the aforesaid goods for use in relation to and relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

35 (Based on 44(e)) Data processing services in the field of healthcare; (Based on Intent To Use) data management, namely, database management, computer data entry services; data processing services; database management; computer data entry services and data processing services; compilation of data for business purposes; automated data processing services; electronic data collection services for business purposes in the fields of medicine and healthcare; systematization of data in computer databases; collating of data in computer databases, namely, compilation and systemization of information into computer databases; market research data analysis; online data processing services; preparation of healthcare statistical data, namely, providing statistical healthcare information for business or commercial purposes; dissemination of data relating to healthcare, namely, providing business information in the field of healthcare, database processing services; data and database improvement, namely, updating and maintenance of data in computer databases; data and database enhancement, namely, updating and maintenance of data in computer databases; combining data from multiple sources into databases, namely, systemization of data in computer databases; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

44 (Based on 44(e)) Healthcare; medical services; hospital services and medical clinics; medical assistance; nursing services; health screening services in the field of cancer; medical information; health care services in the nature of dissemination of data relating to healthcare, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; advisory and consultancy services relating to all of the aforesaid and none of the aforesaid relating to the testing and screening of neurological conditions

42 (Based on 44(e)) Information technology services for the pharmaceutical and healthcare industries, namely, providing information technology consulting services, and providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; (Based on Intent To Use) providing online, non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; software as a service (SaaS) services featuring software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; platform as a service (PaaS) services featuring computer software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software, software as a service (SaaS) services featuring software, platform as a service (PaaS) services featuring computer software platforms and online, non-downloadable software platforms all for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; providing temporary use of online non-downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non- downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; multi-platform digital tools, namely, providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; compilation of data, namely, compiling data for research purposes in the field of medical science and medical consultancy; database improvement, namely, maintenance of on-line databases for others; database enhancement, namely, maintenance of on-line databases for others; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

The mark consists of a stylized letter "C" consisting of three curved lines with the stylized words "THE SIGNS" with the letter "I" as an exclamation mark.
C THE SIGNS
Color is not claimed as a feature of the mark.

Trademark Events

Feb 28, 2024

Notice Of Approval Of Extension Request E-Mailed

Feb 27, 2024

Sou Extension 1 Granted

Feb 27, 2024

Sou Extension 1 Filed

Feb 27, 2024

Sou Teas Extension Received

Sep 12, 2023

Noa E-Mailed - Sou Required From Applicant

Jul 18, 2023

Official Gazette Publication Confirmation E-Mailed

Jul 18, 2023

Published For Opposition

Jun 28, 2023

Notification Of Notice Of Publication E-Mailed

Jun 14, 2023

Law Office Publication Review Completed

Jun 2, 2023

Approved For Pub - Principal Register

Jun 2, 2023

Examiner's Amendment Entered

Jun 2, 2023

Notification Of Examiners Amendment E-Mailed

Jun 2, 2023

Examiners Amendment E-Mailed

Jun 2, 2023

Examiners Amendment -Written

May 2, 2023

Teas/Email Correspondence Entered

May 1, 2023

Correspondence Received In Law Office

May 1, 2023

Teas Response To Office Action Received

Feb 1, 2023

Notification Of Non-Final Action E-Mailed

Feb 1, 2023

Non-Final Action E-Mailed

Feb 1, 2023

Non-Final Action Written

Jan 5, 2023

Preliminary/Voluntary Amendment - Entered

Jan 4, 2023

Assigned To Lie

Nov 7, 2022

Teas Voluntary Amendment Received

Nov 8, 2022

Notification Of Non-Final Action E-Mailed

Nov 8, 2022

Non-Final Action E-Mailed

Nov 8, 2022

Non-Final Action Written

Nov 2, 2022

Assigned To Examiner

Jan 28, 2022

Notice Of Design Search Code E-Mailed

Jan 27, 2022

New Application Office Supplied Data Entered

Jan 27, 2022

New Application Entered